M1 Kliniken AG (MKLNF) Stock
M1 Kliniken AG, along with its affiliated entities, delivers aesthetic and plastic surgery services through a network of medical facilities spanning Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company structures its operations into two core divisions: Beauty and Trade.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About M1 Kliniken AG
M1 Kliniken AG, along with its affiliated entities, delivers aesthetic and plastic surgery services through a network of medical facilities spanning Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company structures its operations into two core divisions: Beauty and Trade. Under its Beauty segment, M1 develops and commercializes a range of pharmaceutical, medical, and medical technology products designed for aesthetic medicine and cosmetic dermatology. These products are distributed to healthcare professionals, pharmacies, and wholesalers under the "M1 Select" brand. The Trade segment focuses on the broad commercial distribution of diverse medical products, including pharmaceuticals, biosimilars, and various medical devices. This trading activity covers critical therapeutic areas such as oncology, HIV treatment, rheumatology, neurology, cardiovascular diseases, and controlled substances. Furthermore, the company is involved in real estate, specifically the acquisition, management, and sale of properties, with a predominant focus on the healthcare sector. M1 Kliniken AG's service infrastructure includes a specialized surgical clinic and approximately 46 dedicated specialist centers operating under the M1 Med Beauty brand. Founded in 2007 and headquartered in Berlin, Germany, M1 Kliniken AG functions as a subsidiary of MPH Health Care AG.
M1 Kliniken AG is headquartered in DE.
M1 Kliniken AG (MKLNF) stock trades at $11.73 with a market capitalization of $214.81M. The stock is valued at a price-to-earnings (P/E) ratio of 15.77, price-to-book of 2.93, price-to-sales of 0.98. Over the past 52 weeks the stock has ranged between $11.73 and $11.73, and currently trades at its 52-week high. It pays a dividend yielding 11.68%.
On profitability, M1 Kliniken AG generates a return on equity (ROE) of 18.60%, above the typical market average, return on capital employed of 21.93%, an operating margin of 9.49%, a net profit margin of 6.08%.
Official website: www.m1-kliniken.de